Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Efficacy And Safety Of Hydroxychloroquine Combined With Methotrexate, Capecitabine And Bevacizumab Vs. Regorafenib In Participants With Refractory Metastatic Colorectal Cancer With Mutations In RAS Genes

Sergey Orlov, MD · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
colorectal-neoplasms
metastatic colorectal cancer (mcrc), colorectal neoplasms, refractory metastatic colorectal cancer, hydroxychloroquine, regorafenib, kras mutation, nras mutation, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 879408
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.